EAGLE PHARMACEUTICALS INC(NASDAQ:EGRX) stock News

EGRX Latest News, Press Relases and Analysis

All

Press Releases

10 months ago - By: Eagle Pharmaceuticals, Inc.

Eagle Pharmaceuticals Adopts Limited Duration Stockholder Rights Plan

a year ago - By: Benzinga - Mentions: CPHI SNGX BBLG PCSA ...

12 Health Care Stocks Moving In Wednesday's After-Market Session

a year ago - By: Benzinga - Mentions: CAG HUM RPM MTC ...

Crude Oil Edges Higher; ConAgra Posts Downbeat Earnings

a year ago - By: Eagle Pharmaceuticals, Inc.

Eagle Pharmaceuticals Announces Receipt of Delisting Notification from Nasdaq

a year ago - By: Eagle Pharmaceuticals, Inc.

Eagle Pharmaceuticals Announces Receipt of Delisting Notification from Nasdaq

a year ago - By: Eagle Pharmaceuticals, Inc.

Eagle Pharmaceuticals to Present Additional Data from Phase III Trial Demonstrating Sustained Response of Amisulpride for the Rescue Treatment of Postoperative Nausea and Vomiting (PONV) at the Upcoming ASPAN 2024 National Conference in Orlando, Florida

a year ago - By: Eagle Pharmaceuticals, Inc.

Eagle Pharmaceuticals Announces Receipt of Notification of Deficiency from Nasdaq Regarding Requirement to Timely File Annual Report on Form 10-K

1 years ago - By: Seeking Alpha

Eagle Pharmaceuticals to cut 36% of workforce (NASDAQ:EGRX)

2 years ago - By: Faruqi & Faruqi, LLP

EAGLE PHARMACEUTICALS SHAREHOLDER ACTION REMINDER: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Eagle Pharmaceuticals To Contact Him Directly To Discuss Their Options

2 years ago - By: The Law Offices of Frank R. Cruz

The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Eagle Pharmaceuticals, Inc. (EGRX)

2 years ago - By: Faruqi & Faruqi LLP

EAGLE PHARMACEUTICALS 48 HOUR DEADLINE ALERT: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Eagle Pharmaceuticals To Contact Him Directly To Discuss Their Options

2 years ago - By: The Law Offices of Vincent Wong

SHAREHOLDER ALERT: The Law Offices of Vincent Wong Remind Eagle Pharmaceuticals Investors of a Lead Plaintiff Deadline of February 9, 2024

2 years ago - By: Pomerantz LLP

SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Eagle Pharmaceuticals, Inc. - EGRX

2 years ago - By: Levi & Korsinsky, LLP

SHAREHOLDER ALERT: Levi & Korsinsky Notifies Eagle Pharmaceuticals, Inc.(EGRX) Investors of a Class Action Lawsuit and Upcoming Deadline

2 years ago - By: Bragar Eagel & Squire - Mentions: INSP DRVN GDHG

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Eagle Pharmaceuticals, Golden Heaven, Inspire Medical, and Driven and Encourages Investors to Contact the Firm

2 years ago - By: The Rosen Law Firm PA

ROSEN, NATIONAL TRIAL COUNSEL, Encourages Eagle Pharmaceuticals, Inc. Investors to Secure Counsel Before Important February 9 Deadline in Securities Class Action – EGRX

2 years ago - By: THE ROSEN LAW FIRM, P. A.

ROSEN, TOP RANKED NATIONAL INVESTOR ATTORNEYS, Encourages Eagle Pharmaceuticals, Inc. Investors to Secure Counsel Before Important February 9 Deadline in Securities Class Action - EGRX

2 years ago - By: Faruqi & Faruqi, LLP

EAGLE PHARMACEUTICALS SHAREHOLDER ACTION REMINDER: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Eagle Pharmaceuticals To Contact Him Directly To Discuss Their Options

2 years ago - By: The Rosen Law Firm PA

ROSEN, A LEADING LAW FIRM, Encourages Eagle Pharmaceuticals, Inc. Investors to Secure Counsel Before Important February 9 Deadline in Securities Class Action – EGRX

2 years ago - By: Faruqi & Faruqi LLP

EAGLE PHARMACEUTICALS INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Eagle Pharmaceuticals To Contact Him Directly To Discuss Their Options

2 years ago - By: The Law Offices of Vincent Wong

SHAREHOLDER ALERT: The Law Offices of Vincent Wong Remind Eagle Pharmaceuticals Investors of a Lead Plaintiff Deadline of February 9, 2024

2 years ago - By: Bragar Eagel & Squire - Mentions: MVST GDHG INSP

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Microvast, Eagle Pharmaceuticals, Golden Heaven, and Inspire Medical and Encourages Investors to Contact the Firm

2 years ago - By: Levi & Korsinsky, LLP

SHAREHOLDER ALERT: Levi & Korsinsky Notifies Eagle Pharmaceuticals, Inc. (EGRX) Investors of a Class Action Lawsuit and Upcoming Deadline

2 years ago - By: Bragar Eagel & Squire - Mentions: MVST GDHG INSP

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Microvast, Eagle Pharmaceuticals, Golden Heaven, and Inspire Medical and Encourages Investors to Contact the Firm

2 years ago - By: THE ROSEN LAW FIRM, P. A.

ROSEN, A LEADING LAW FIRM, Encourages Eagle Pharmaceuticals, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - EGRX

2 years ago - By: Faruqi & Faruqi, LLP

EAGLE PHARMACEUTICALS INVESTOR DEADLINE APPROACHING: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Eagle Pharmaceuticals To Contact Him Directly To Discuss Their Options

2 years ago - By: The Law Offices of Vincent Wong

EAGLE PHARMACEUTICALS INC (EGRX) Stock News

EGRX Latest News, Press Relases and Analysis